Search INGN
Inogen, Inc.
NasdaqGS · CIK 1294133
Last close5.97
Daily change-0.01 (-0.17%)
10 Years gain-89.96%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
INGN · STANDARD
SIC 3842 · Orthopedic, Prosthetic & Surgical Appliances & Supplies · Fiscal year end 1231
Fundamental
32.5Momentum
75.0Acceleration
77.5Confidence
83.0Annual Revenue14
Quarterly Revenue59
Annual CFO10
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth4.6 / 25
Quality5.1 / 25
Capital Efficiency4.0 / 20
Balance Sheet15.0 / 15
Shareholder Economics2.1 / 10
Forward Indicators0.0 / 5
Signals
Operating leverageOperating margin improved by 4.9979 percentage points.
ROIC expansionROIC improved by 6.2313 percentage points.
Warnings
Gross margin compression · MEDIUMGross margin compressed by 2.982 percentage points.
Heavy share dilution · HIGHDiluted share count increased 7.4734%.
Key Metrics
Revenue Growth TTM11.84%OK
Revenue CAGR 3Y-2.7%OK
Gross Margin52.13%OK
Operating Margin-8.81%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC-29.47%OK
Incremental Operating Margin 3Y-1,500.08%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y7.47%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $295.30M | $154.27M | -$30.21M | -$11.22M | -$13.74M | 52.24% | -10.23% | -4.65% | -35.96% | 26.6M |
| 2025 FY Dec 31, 2024 | $278.76M | $154.74M | -$42.52M | $5.91M | $2.55M | 55.51% | -15.25% | 0.92% | -49.25% | 23.65M |
| 2025 FY Dec 31, 2023 | $251.61M | $126.70M | -$109.39M | -$3.23M | -$8.45M | 50.36% | -43.47% | -3.36% | -92.55% | 23.18M |
| 2024 FY Dec 31, 2022 | $320.55M | $153.53M | -$85.24M | -$37.53M | -$40.87M | 47.9% | -26.59% | -12.75% | -57.29% | 22.85M |
| 2023 FY Dec 31, 2021 | $311.73M | $176.48M | $9.24M | $23.63M | $18.15M | 56.61% | 2.96% | 5.82% | 4.94% | 22.49M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $314.19M | sum latest 4 fiscal quarters Revenue | OK | 0001294133-26-000034, 0001193125-25-269484 |
| Revenue Growth TTM | 11.84% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001294133-26-000034, 0001193125-25-269484 |
| Revenue CAGR 3Y | -2.7% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001193125-26-082630 |
| Revenue CAGR 5Y | 1.06% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001193125-26-082630 |
| Gross Profit CAGR 3Y | 0.16% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001193125-26-082630 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001294133-26-000034, 0001193125-25-269484 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 52.13% | Gross Profit / Revenue | OK | 0001294133-26-000034, 0001193125-25-269484 |
| Operating Margin | -8.81% | Operating Income / Revenue | OK | 0001294133-26-000034, 0001193125-25-269484 |
| ROIC | -29.47% | NOPAT / Average Invested Capital | OK | 0001294133-26-000034, 0001193125-25-269484 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001294133-26-000034 |
| Current Ratio | 2.74x | Current Assets / Current Liabilities | OK | derived |
| Revenue per Diluted Share | $11.62 | Revenue / Diluted Shares | OK | 0001294133-26-000034, 0001193125-25-269484 |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |